Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality
Veli‐Pekka Harjola(University of Helsinki), José Silva‐Cardoso(Universidade do Porto), Lars Køber(Copenhagen University Hospital), Tuukka Tarvasmäki(University of Helsinki), Alessandro Sionís, Reijo Sund, Marjut Varpula(University of Helsinki), Johan Lassus(University of Helsinki), Alexandre Mebazaa(Délégation Paris 5), John Parissis(National and Kapodistrian University of Athens), Valentina Carubelli(Surgical Specialties (Canada)), Jindřich Špinar(University Hospital Brno), Salvatore Di Somma(Clinique Saint Pierre), Marek Banaszewski(Institute of Cardiology)
Cited by 204
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k